rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1990-10-2
|
pubmed:abstractText |
The effect of renal function on the bioavailability of ciprofloxacin was studied in 21 subjects with measured creatinine clearances ranging from 0 to 8.99 liters/h per 1.73 m2. Each subject received ciprofloxacin, 200 mg intravenously and 750 mg orally, separated by at least 1 week. Serial (12 to 15) blood samples were obtained over 24 to 48 h. Concentrations in serum were assayed by high-pressure liquid chromatography. Area under the curve was calculated by the trapezoidal rule with extrapolation to infinity. Bioavailability was calculated as the ratio between the dose-normalized area under the curve of oral and intravenous administrations. The overall mean (standard deviation) bioavailability observed was 63.4% (14.6%), similar to that observed in those with normal renal function (69.0% [15.7%]). The mean bioavailability in the subgroup of subjects with renal insufficiency was 59.9% (13.3%). The observed range in bioavailability was 33.9 to 91.4%. Linear regression did not reveal a correlation between creatinine clearance and bioavailability. Renal insufficiency does not appear to affect ciprofloxacin bioavailability.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0066-4804
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1031-4
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:2393263-Administration, Oral,
pubmed-meshheading:2393263-Adult,
pubmed-meshheading:2393263-Biological Availability,
pubmed-meshheading:2393263-Chronic Disease,
pubmed-meshheading:2393263-Ciprofloxacin,
pubmed-meshheading:2393263-Female,
pubmed-meshheading:2393263-Glomerulonephritis,
pubmed-meshheading:2393263-Humans,
pubmed-meshheading:2393263-Hypertension,
pubmed-meshheading:2393263-Injections, Intravenous,
pubmed-meshheading:2393263-Kidney,
pubmed-meshheading:2393263-Kidney Diseases,
pubmed-meshheading:2393263-Male,
pubmed-meshheading:2393263-Middle Aged
|
pubmed:year |
1990
|
pubmed:articleTitle |
Effect of renal function on the bioavailability of ciprofloxacin.
|
pubmed:affiliation |
University of Maryland School of Pharmacy, Baltimore 21201.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|